Literature DB >> 22865898

Physical activity in relation to serum sclerostin, insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: a cross-sectional and a longitudinal study.

Mohammed-Salleh M Ardawi1, Abdulrahim A Rouzi, Mohammed H Qari.   

Abstract

CONTEXT: There is limited information on the effects of mechanical loading caused by physical activity (PA) on sclerostin, IGF-I, and bone turnover markers (BTM).
OBJECTIVE: The objective of the investigation was to study the relationships between serum sclerostin, serum-IGF-I (s-IGF-I), BTM, and the PA level in premenopausal women and to discern how 8 wk of PA training (PAT) affects the serum levels of sclerostin, IGF-I, and BTM.
DESIGN: This was a cross-sectional study with a subgroup followed up longitudinally. SETTINGS AND
SUBJECTS: A total of 1235 randomly selected premenopausal women were cross-sectionally studied. We also followed up 58 of these women longitudinally during an 8-wk course of PAT (4 d/wk) and compared them with 62 controls. All women were medically examined, and bone mineral density (BMD) and serum levels of sclerostin, s-IGF-I, and BTM were determined.
RESULTS: Women with PA of greater than 120 min/wk showed significantly lower serum sclerostin (by 36.8%) but higher s-IGF-I (by 107%) levels than sedentary controls. Bone formation markers were also higher in the PA greater than 120 min/wk group compared with the sedentary controls. In the longitudinal study, the 8-wk PAT program led to a decrease in serum sclerostin (by 33.9%, P<0.0001) but increases in the serum levels of the bone-formation markers and IGF-I (s-IGF-I by 74.2%, P<0.0001).
CONCLUSIONS: This study demonstrates that even minor changes in PA are associated with effects on serum levels of sclerostin, IGF-I, and BTM and suggests that sclerostin could be a link between mechanical loading and disuse osteoporosis in humans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22865898     DOI: 10.1210/jc.2011-3361

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  45 in total

1.  Sarcopenia Is Associated with Cognitive Impairment in Older Adults: A Systematic Review and Meta-Analysis.

Authors:  G Cabett Cipolli; M Sanches Yassuda; I Aprahamian
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

2.  Comparison of two commercially available ELISAs for circulating sclerostin.

Authors:  A G Costa; S Cremers; E Dworakowski; M Lazaretti-Castro; J P Bilezikian
Journal:  Osteoporos Int       Date:  2014-02-22       Impact factor: 4.507

3.  A pilot study to relationship between urinary protein excretion and muscle strengthening in patients with acute onset renal disease.

Authors:  Kohji Iwai; Yasuhiko Hatanaka
Journal:  Phys Ther Res       Date:  2018-07-15

4.  Genetic variation in Wnt/β-catenin and ER signalling pathways in female and male elite dancers and its associations with low bone mineral density: a cross-section and longitudinal study.

Authors:  T Amorim; C Durães; J C Machado; G S Metsios; M Wyon; J Maia; A D Flouris; F Marques; L Nogueira; N Adubeiro; Y Koutedakis
Journal:  Osteoporos Int       Date:  2018-07-05       Impact factor: 4.507

5.  Physical activity and hypocaloric diet recovers osteoblasts homeostasis in women affected by abdominal obesity.

Authors:  Viviana M Bimonte; Simona Fittipaldi; Chiara Marocco; Gian Pietro Emerenziani; Rachele Fornari; Laura Guidetti; Eleonora Poggiogalle; Emanuele Nicolai; Luigi Di Luigi; Lorenzo M Donini; Carlo Baldari; Andrea Lenzi; Emanuela A Greco; Silvia Migliaccio
Journal:  Endocrine       Date:  2016-12-16       Impact factor: 3.633

Review 6.  The Non-invasive Diagnosis of Bone Disorders in CKD.

Authors:  Jordi Bover; Pablo Ureña-Torres; Mario Cozzolino; Minerva Rodríguez-García; Carlos Gómez-Alonso
Journal:  Calcif Tissue Int       Date:  2021-01-04       Impact factor: 4.333

Review 7.  Hormonal and systemic regulation of sclerostin.

Authors:  Matthew T Drake; Sundeep Khosla
Journal:  Bone       Date:  2016-12-10       Impact factor: 4.398

8.  Exercise during energy restriction mitigates bone loss but not alterations in estrogen status or metabolic hormones.

Authors:  C E Metzger; K Baek; S N Swift; M J De Souza; S A Bloomfield
Journal:  Osteoporos Int       Date:  2016-04-29       Impact factor: 4.507

9.  Differential sclerostin and parathyroid hormone response to exercise in boys and men.

Authors:  B Falk; F Haddad; P Klentrou; W Ward; K Kish; Y Mezil; S Radom-Aizik
Journal:  Osteoporos Int       Date:  2015-09-11       Impact factor: 4.507

10.  Sclerostin and bone strength in women in their 10th decade of life.

Authors:  Sara Thorson; Tanushree Prasad; Yahtyng Sheu; Michelle E Danielson; Aarthi Arasu; Steven R Cummings; Jane A Cauley
Journal:  J Bone Miner Res       Date:  2013-09       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.